Revvity, Inc. (RVTY) Gross Margin: 51.44%
Is Revvity, Inc.’s gross margin high or low?
Revvity, Inc.'s gross margin of 51.44% is in line with its 5-year average of 52.43%, near the low end of its 5-year range (48.01%–59.62%).
As of Wednesday, June 17, 2026. 1.77% above its 12-month average of 50.55%.
RVTY Gross Margin Chart
RVTY Average Gross Margin Chart
RVTY Current vs Average Gross Margin Chart
RVTY Gross Margin Metrics
GROSS MARGIN
51.44%
GROSS MARGIN AVG TTM
50.55%
GROSS MARGIN AVG 3Y
50.58%
GROSS MARGIN AVG 5Y
52.43%
GROSS MARGIN AVG 10Y
49.11%
GROSS MARGIN AVG 15Y
46.49%
GROSS MARGIN AVG 20Y
45.35%
CURRENT VS TTM AVG
+1.77%
CURRENT VS 3Y AVG
+1.70%
CURRENT VS 5Y AVG
-1.88%
CURRENT VS 10Y AVG
+4.75%
CURRENT VS 15Y AVG
+10.64%
CURRENT VS 20Y AVG
+13.42%
RVTY Competitors' Gross Margin
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revvity, Inc. (RVTY) | $10.91B | 51.44% | 50.55% | 50.58% | 52.43% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 17.13% | 18.71% | 19.98% | 20.79% |
| Baxter International Inc. (BAX)vs › | $10.19B | 30.11% | 33.76% | 35.72% | 36.84% |
| Align Technology, Inc. (ALGN)vs › | $12.43B | 67.68% | 69.16% | 69.73% | 70.75% |
| The Cooper Companies, Inc. (COO)vs › | $12.69B | 64.37% | 63.66% | 64.40% | 64.61% |
| Solventum Corporation (SOLV)vs › | $12.91B | 53.67% | 54.56% | 56.03% | 57.27% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.78B | 31.86% | 31.70% | 34.15% | 35.17% |
| Medpace Holdings, Inc. (MEDP)vs › | $13.05B | 29.07% | 30.59% | 29.65% | 29.57% |
| Tempus AI, Inc. (TEM)vs › | $8.51B | 69.55% | 62.30% | 54.75% | 44.45% |
| DaVita Inc. (DVA)vs › | $13.52B | 31.10% | 29.95% | 30.17% | 30.48% |
Gross Margin Analysis
Gross Margin
51.4%
(Revenue - COGS) / Revenue
Revvity, Inc. Gross Margin Formula & Definition
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Revvity, Inc. Gross Margin FAQ
- What is the gross margin for Revvity, Inc. (RVTY)?
- The gross margin for RVTY stock is 51.44%.
- Is Revvity, Inc.'s gross margin high or low?
- Revvity, Inc.'s gross margin of 51.44% is in line with its 5-year average of 52.43%, near the low end of its 5-year range (48.01%–59.62%).
- What is the TTM average gross margin for Revvity, Inc. (RVTY)?
- The TTM average gross margin for RVTY stock is 50.55%.
- What is the 3Y average gross margin for Revvity, Inc. (RVTY)?
- The 3Y average gross margin for RVTY stock is 50.58%.
- What is the 5Y average gross margin for Revvity, Inc. (RVTY)?
- The 5Y average gross margin for RVTY stock is 52.43%.
- What is the 10Y average gross margin for Revvity, Inc. (RVTY)?
- The 10Y average gross margin for RVTY stock is 49.11%.
- What is the 15Y average gross margin for Revvity, Inc. (RVTY)?
- The 15Y average gross margin for RVTY stock is 46.49%.
- What is the 20Y average gross margin for Revvity, Inc. (RVTY)?
- The 20Y average gross margin for RVTY stock is 45.35%.
Revvity, Inc. Gross Margin History
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-28 | 53.08% |
| 2024-12-29 | 48.01% |
| 2023-12-31 | 48.07% |
| 2022-12-31 | 53.16% |
| 2021-12-31 | 59.62% |
| 2020-12-31 | 52.62% |
| 2019-12-31 | 44.84% |
| 2018-12-31 | 45.04% |
| 2017-12-31 | 45.61% |
| 2016-12-31 | 45.96% |
| 2015-12-31 | 44.19% |
| 2014-12-31 | 43.40% |
| 2013-12-31 | 43.39% |
| 2012-12-31 | 43.67% |
| 2011-12-31 | 42.89% |
| 2010-12-31 | 43.44% |
| 2009-12-31 | 45.07% |
| 2008-12-31 | 42.61% |
| 2007-12-31 | 40.01% |
| 2006-12-31 | 40.32% |
| 2005-12-31 | 41.70% |
| 2004-12-31 | 40.78% |
| 2003-12-31 | 40.97% |
| 2002-12-31 | 39.93% |
| 2001-12-31 | 45.74% |
| 2000-12-31 | 45.82% |
| 1999-12-31 | 42.24% |
| 1998-12-31 | 29.59% |
| 1997-12-31 | 28.80% |
| 1996-12-31 | 29.39% |
Related Metrics
About Revvity, Inc.
Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Prahlad R. Singh